Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reassessing pharmacogenomic cell sensitivity with multilevel statistical models

Biostatistics(2022)10.1093/biostatistics/kxac010Source: DataRank Database

Reassessing pharmacogenomic cell sensitivity with multilevel statistical models is a research paper published in Biostatistics (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: bronzeTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Rafael A. Irizarry ORCID,Matt Ploenzke

Live enrichment

PubMed:35277956 PMC:PMC10583722 OpenAlex:https://openalex.org/W4212795446

National Institutes of Health

Grant: CA09337

National Institutes of Health

Grant: R35GM131802

National Institutes of Health

Grant: P41HG004059

NCI NIH HHS

Grant: T32 CA009337

National Institutes of Health

Grant: 2R35GM131802-06

Data Analysis Tools for Emerging High-throughput Technologies

National Institutes of Health

Grant: 3P41HG004059-04S1

Bioconductor: an open computing resource for genomics

FWCI

0.00

Citation Percentile

0.0%

Citation Trend

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/biostatistics/advance-article-pdf/doi/10.1093/biostatistics/kxac010/42869868/kxac010.pdf

publisherhttps://academic.oup.com/biostatistics/advance-article-pdf/doi/10.1093/biostatistics/kxac010/42869868/kxac010.pdf

publisherhttps://academic.oup.com/biostatistics/article-pdf/24/4/901/52215303/kxac010.pdf

journalhttps://doi.org/10.1093/biostatistics/kxac010

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35277956

Fields of Study

Lung Cancer Treatments and MutationsCancer Genomics and DiagnosticsChronic Lymphocytic Leukemia Research0301 basic medicine03 medical and health sciences0101 mathematics01 natural sciencesHumansCrizotinibCarcinoma, Non-Small-Cell LungLung NeoplasmsPharmacogeneticsModels, StatisticalReceptor Protein-Tyrosine Kinases

MeSH Terms

CrizotinibCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsPharmacogeneticsModels, StatisticalReceptor Protein-Tyrosine Kinases

Keywords

PharmacogenomicsPairwise comparisonCrizotinibSensitivity (control systems)Computational biologyComputer scienceStatisticsMathematicsBioinformaticsBiologyMedicineOncologyBayesian analysisStatistical ModelingStatistical Methods In PharmacologyLung NeoplasmsModels, StatisticalPharmacogeneticsCarcinoma, Non-Small-Cell LungHumansReceptor Protein-Tyrosine Kinases

Sustainable Development Goals

SDG 0: Good health and well-being

Reassessing pharmacogenomic cell sensitivity with multilevel statistical models

FAIR Checklist

Authors (2)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)